Connect with us

What's Lit

The Highest Yielding Strains • Uncategorized

Published

on


Weed. Pot. Mary Jane. Cannabis. Whatever you call it, there’s no denying that this herb has become increasingly popular in recent years. Whether you’re a casual smoker or a full-blown stoner, chances are you’re always on the lookout for new strains to try. And what better place to find them than the highest yielding strains?

So sit back, relax, and let us do the work for you. We’ve scoured the internet and identified the top 10 highest yielding cannabisThis post contains affiliate links! strains out there. So whether you’re looking for a new strain to grow or just want to know what’s out there, this is the list for you!

The Highest Yielding Strains: An Introduction

If you’re looking to produce a large quantity of cannabisThis post contains affiliate links!, you need to start with high-yielding strains. These strains have been specifically bred to produce large amounts of buds (the flowers of the female cannabisThis post contains affiliate links! plant that contain the THC). To give you an idea of the potential yield, some of the highest yielding strains can produce up to 700g per plant! But remember, the actual yield will depend on a number of factors such as growing conditions, experience and luck.

In this guide, we will introduce you to some of the highest yielding strains available. We will also provide some tips on how to maximize your yield potential.

So, if you’re ready to start growing cannabis for its medicinal or recreational properties, read on for our guide to high yield seeds.

Advertisement

The Top 10 Highest Yielding Strains

In general, there are three types of cannabis strains – indicas, sativas, and hybrids. Out of these, indica plants are shorter with leaves that are wider and denser. They grow faster and have a higher yield as compared to the other two types. If you’re looking for a list of the highest yielding indica strains, here it is:

  1. Blue Cheese – This strain has a high yield of up to 550 grams per square meter. It is a hybrid of 60% indica and 40% sativa.
  2. Northern Lights – A classic indica strain that has won many awards, Northern Lights has a yield of 500-600 grams per square meter.
  3. White Widow – One of the most popular strains out there, White Widow has a yield of 450-500 grams per square meter.
  4. Master Kush – A pure indica strain, Master Kush has a yield of 400-500 grams per square meter.
  5. OG Kush – Another popular strain, OG Kush has a yield of 400-500 grams per square meter.
  6. Granddaddy Purple – A purple-colored strain, Granddaddy Purple has a yield of 400-500 grams per square meter.
  7. Chocolate Diesel – As the name suggests, this strain has a chocolatey flavor and aroma with diesel undertones. It has a yield of 350-450 grams per plant outdoors and 500-550 grams per square meter indoors.
  8. Blackberry Kush – A hybrid of 80% indica and 20% sativa, Blackberry Kush has a sweet berry flavor with earthy undertones. It has a yield of 300-400 grams per plant outdoors and 450-500 grams per square meter indoors..

9.-10 Blue Mystic – A mostly indica hybrid , it produces dense buds tinged blue with violet hues . The flowering time is only 8 weeks , making it one great choice for first time growers 350 – 400 g/m2

The Benefits of Growing High Yielding Strains

When it comes to cannabis, more is often better. More yield, more THC, more CBD, etc. There are many factors that affect a plant’s yield, from the grower’s technique to the strain itself. In this article, we’ll be focusing on the latter by discussing the highest yielding strains available.

While there are many different ways to measure a strain’s yield, we’ll be using grams per square meter (g/m²) as our metric. This is a widely used standard that allows for easy comparison between strains. With that said, let’s jump right in!

  1. Green Crack: First on our list is Green Crack, a sativa-dominant hybrid with explosive yields of up to 625 g/m². This strain is known for being easy to grow and resistant to mold and pests, making it a great choice for first-time growers. Green Crack is also relatively fast-flowering for a sativa, with a typical flowering time of 9 weeks.
  2. Blue Dream: Another popular strain among growers, Blue Dream yields an impressive 600 g/m² indoors and even more when grown outdoors. This hybrid is perfect for beginners as it’s easy to grow and relatively resistant to common problems like mold and pests. Blue Dream has a sweet berry aroma and Flavoring , making it a great choice for those looking for something different .
  3. 3 . Granddaddy Purple: Next on our list is Granddaddy Purple , A classic indica strain with deep purple buds , This ganja produces yields of up to 550 g/m² . Granddaddy Purple is loved by growers for its ease of cultivation and tolerance of cold weather .This potent indica has high THC levels , averaging at around 20% . However , its CBD levels are rather low , typically around 1% .
  4. 4 . Trainwreck: A potent sativa-dominant hybrid , Trainwreck yields up to 525 g/m² indoors. It’s one of the easier strains to grow , making it a good choice for beginner growers . Trainwreck has high THC levels , averaging at 21% . However , its CBD levels are rather low , typically below 1% . This strain gets its name from its mind-bending effects that “wreck” your train of thought . 5 . White Widow: Last but not least on our list is White Widow , A world-famous hybrid that was first introduced in the 1990s White Widow is still one of the most popular strains today due to its impressive yields (up to 500 g/m² indoors) and relatively short flowering time (usually around 8 weeks) This well-balanced hybrid has moderate THC levels (around 18%) and low CBD levels (around 0.5%)

strains-marijuana-term

The Drawbacks of Growing High Yielding Strains

Crosses between different varieties of cannabis can lead to unpredictable results. A hybrid can take on characteristics from either parent, or be significantly different from both. This is why many growers prefer to work with purebred strains, which are more likely to produce predictably uniform offspring.

However, some growers prefer to work with high yielding strains, even though they may be less predictable. High yielding strains are those that produce more buds, and thus more yield, per plant. While there are some drawbacks to growing high yielding strains, the increased yield may be worth the extra effort for some growers.

Advertisement

Drawbacks of Growing High Yielding Strains

  1. Increased likelihood of hermaphroditism.
  2. Increased likelihood of problems with nutrient deficiency and excess.
  3. More difficult to control the environment (e.g., temperature, humidity).
  4. Requires more experience and knowledge to grow successfully.

How to Grow the Highest Yielding Strains

The term “highest yielding strains” can be a bit misleading. There are many variables that come into play when growing cannabisThis post contains affiliate links!, and yield is only one of them. That being said, there are certain strains that have a reputation for being high yielding, and if you’re looking to maximize your harvest, these are the ones you should be growing. Purchase from United Cannabis Seeds if you are looking for a reputable seed bank.

Here are some tips for growing the highest yielding strains:

-Choose a strain that is known to produce high yields. Some good options include White Widow, Northern Lights, and G-13.

-Make sure you are growing in optimal conditions. This includes using quality soil and nutrients, providing adequate light and ventilation, and maintaining a consistent temperature.

-Train your plants early on. This will help them to grow more horizontal branches which will in turn produce more buds.

Advertisement

-Be patient! Don’t try to rush the process by harvesting early. Allow your plants to mature fully so that they reach their maximum potential yield.

– Search for high yield seeds from a reputable us seed bank that has great reviews on TrustPilot and Google

Tips for Growing High Yielding Strains

Every grower wants to get the most they can out of their harvest, and there are many ways to increase yield. One method is to choose high yielding strains, and this can be done by doing some research on the best strains for yield. You can also talk to experienced growers or dispensary staff members for recommendations. Another way to increase yield is by using techniques like topping, which is when you remove the growing tip of the plant to encourage it to grow lateral branches. These branches will then produce more flowers or buds.

Here are some tips for growing high yielding strains:

-Do your research: As mentioned, part of growing high yield strains is choosing the right ones. Make sure to do your research on different strains and find out which ones have the highest yields. You can ask other growers, dispensary staff, or look up information online.

Advertisement

-Topping: Remove the growing tip of the plant (the main stem) to encourage lateral branching. This will result in more flowers or buds. Topping is typically done once the plant has reached a certain height, so make sure to do some research on when to top your particular strain.

-Fertilize: Make sure to fertilize your plants regularly with a quality fertilizer. This will ensure that they have all the nutrients they need to grow healthy and strong, and ultimately produce more buds or flowers.

-Prune: Pruning involves removing dead or dying leaves and branches from your plants. This allows them to focus their energy on producing new growth, which can lead to increased yields.

By following these tips, you’ll be well on your way to growing high yielding strains that will give you a bountiful harvest!

The Bottom Line on High Yielding Strains

So, which strains give the highest yields? As a general rule, indica strains tend to produce more buds (and therefore greater yields) than sativas. This is because indicas tend to be shorter and bushier than sativas, with more nodes (where leaves and flowers grow) along their stems.

Advertisement

FAQs About High Yielding Strains

Q: how many pounds per plant can I expect?

Answer: It really depends on the individual strain, however most high yielding strains will produce 1-2 lbs per plant. Some may even produce up to 3 lbs!

Q: What are some good high yielding strains?

Answer: Some of our favorite high yielding strains include White Widow, Girl Scout Cookies, and Granddaddy Purple.

 

Advertisement



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

What's Lit

Washington State Settles With Unicorn Brands Following Synthetic THC Probe

Published

on


The Liquor and CannabisThis post contains affiliate links! Board in the state of Washington said Wednesday that it has reached a settlement with Unicorn Brands LLC over a “a year-long investigation and multiple Administrative Violation Notices (AVNs) for creating synthetically-derived THC from hemp and distributing it into the state-regulated cannabis market.”

The board said that Unicorn Brands “cooperated with the investigation” and ceased the conversion process that was under question. Last summer, the Liquor and Cannabis Board issued a policy statement that “made clear that synthetically-derived THC from hemp was prohibited under current rules and law.”

“This was an important case about the integrity of the legal cannabisThis post contains affiliate links! system voters approved ten years ago and which today flourishes in Washington with a carefully controlled system of production, processing and selling of cannabis to adults,” Liquor and CannabisThis post contains affiliate links! Board chair David Postman said in an email to marijuanaThis post contains affiliate links! license holders in the state, reminding the businesses “of the prohibition on the sort of laboratory conversions involved in the Unicorn case.”

Advertisement

In October of last year, the board’s Education and Enforcement Division issued an Administrative Violation Notices to Unicorn Brands for four violations in its synthesis process: “1) Misuse of License, 2) Criminal Conduct, 3) Noncompliant Extraction, and 4) Traceability Failure.”

Under the terms of the “comprehensive settlement” between the two sides, the board said that Unicorn Brands “will not resume converting hemp into THC and brings an end to a lengthy and complex investigation.”

The board provided more details on the back-and-forth that preceded this week’s settlement.

“After extensive negotiations, the agency and Unicorn reached an agreement to settle these cases. As part of this settlement, the Enforcement and Education Division has agreed to fully withdraw the alleged criminal conduct charge,” the board said in a statement. “In exchange, Unicorn stipulates and fully admits to the remaining three violations: Misuse of License, Noncompliant Extraction, and Traceability Failure. Further, Unicorn has agreed to pay the standard monetary penalties for the three stipulated violations, accept forfeiture of the seized products, and waive further administrative review. Finally, Unicorn has agreed to the condition that “it shall not use its license to produce or manufacture Delta‑8 THC, Delta-9 THC, or any similar synthetically-produced THC from any hemp-based sources in the State of Washington unless explicitly authorized by a subsequent change in state law that allows the licensee to do so.”

The case highlights concerns surrounding the burgeoning Delta-8 market, with state regulators throughout the country struggling to stay on top of new (and, in some cases, illicit) products.

Advertisement

In its press release on Wednesday, the Liquor and Cannabis Board called on lawmakers in Washington to take steps toward providing greater regulation on that front.

“The next important step in protecting the public health is to eliminate the burgeoning market for Delta 8 products and other synthetically-derived products outside the regulated market. These gummies and other edibles are being illegally sold in convenience stores and online in Washington and across the country. We hope the 2023 legislative session will see action to assist in eliminating these illegal sales,” the board said.

Regulation of Delta-8 is far from the only pressing matter facing Washington’s cannabis industry. The state experienced a surge in armed robberies of cannabis dispensaries earlier this year, a problem attributed to the large sums of cash on hand at such retailers.

A spokesperson for the Liquor and CannabisThis post contains affiliate links! Board said in February that the agency recommended dispensary owners “hire armed security guards, make frequent cash deposits so there isn’t much cash available in shops, post signs in businesses explaining that staff don’t have access to much cash, clearly communicate safety guidelines with staff so they know what to do in the event of a robbery.”



Source link

Advertisement

Continue Reading

What's Lit

Japanese Health Officials Propose Revision of Law To Allow Import, Medical Cannabis

Published

on


The Japanese Ministry of Health, Labour, and Welfare stated on Sept. 29 that it recommends an amendment to the country’s drug law, known as the CannabisThis post contains affiliate links! Control Act. According to Reuters, the agency expressed the need to allow cannabis to be imported and permitted for medical use, which would align it with other countries that already have established medical cannabis programs.

Medical cannabis would be regulated like pharmaceuticals, and “would apply to marijuanaThis post contains affiliate links! products whose safety and efficacy were confirmed under laws governing pharmaceuticals and medical devices,” according to Reuters.

According to translated documents published on Sept. 28 by the Japanese Ministry of Health, Labour, and Welfare, a large number of individuals contributed to the review and recommendations, including professors and medical professionals. According to the report, only 1.4% of people in Japan report having ever used cannabis. In western countries, consumer percentages range between 20-40%.

Advertisement

In the U.S., Epidiolex is the first CBD medicine approved by the Food and Drug Administration (FDA) for treating children with epilepsy, and specifically those who suffer from Lennox-Gastaut syndrome, Dravet’s syndrome, and tuberous sclerosis complex. As of March 2019, Epidiolex began undergoing clinical trials in Japan, although there have been no further reports or updates. The trials are exempt from the country’s Cannabis Control Act, which prohibits cannabisThis post contains affiliate links! import/export and consumption. At the time, the country reported having 3,000 residents who suffer from Dravet syndrome, and 4,300 who suffer from Lennox-Gastaut syndrome.

In its current form, the Cannabis Control Act is limiting all forms of progress in relation to cannabis, including hemp.

In January 2021, the Hokkaido Industrial Hemp Association (HIHA) released a statement addressing the Japanese Ministry of Health, Labour, and Welfare’s investigation on cannabis and other drugs. “The Cannabis Control Act is a profoundly unreasonable law that restricts all cannabis regardless of the quantity or even presence of THC (Tetrahydrocannabinol, the active ingredient in marijuanaThis post contains affiliate links!, the chemical synthetic substance of which are designated as an illegal drug in Japan), and even prohibits the cultivation of hemp from overseas (see note below) containing none of this substance,” HIHA wrote. “First, concerning the Cannabis Control Act and problems with its application, we would like to recommend the development of a more reasonable law formulated based upon discussion that is made public to the citizens of Japan and upon scientific knowledge.”

HIHA concluded that the CannabisThis post contains affiliate links! Control Act is preventing the hemp industry from flourishing since it was enacted in 1948. “In order to develop a hemp industry on par with those overseas and protect national interests concerning industrial hemp, this country must revise the Cannabis Control Act and other related laws as soon as possible, position the hemp industry appropriately within the legal system, and strike a balance between the control of drugs and the encouragement of industry.”

In August 2021, the Japanese Ministry of Health, Labour, and Welfare released a report detailing their recommendations for allowing medical cannabis for patients. Earlier this year in May, the ministry met again to continue the discussion of medical cannabis, addressing the need for treatment for those who abuse cannabis use and how to address youth consumption.

Advertisement

In December 2021, the gaming company Capcom partnered with the Osaka Prefectural Police to use its fictional character Ace Attorney to campaign against cannabisThis post contains affiliate links! youth consumption. According to the Japanese National Police Agency, there were 5,482 people who were caught violating the country’s cannabis law (4,537 were in possession of cannabis, while 273 were illegally selling the plant, and 230 were arrested for illegally cultivating). Beatles band member Paul McCartney received an 11-year ban from Japan for possessing half a pound of cannabis back in 1980.



Source link

Continue Reading

What's Lit

Canadian Government Tells Hockey Players in Russia, Belarus To Leave

Published

on


The Canadian federal government recently sent word to hockey teams traveling in Russia and Belarus to leave as soon as possible, according to the Toronto Sun. Forty-eight Canadian hockey athletes are on the roster for the Kontinental Hockey League, and 44 of them are playing in Russia and Belarus (the other four are in Kazakhstan).

Russia invaded Ukraine on Feb. 24, and Canada was an early supporter of Ukraine since the war began. The Canadian government has given $626 million in military aid, and $320 in humanitarian relief. “Our government has been very clear. Canadians should avoid all travel to Russia and Belarus,” Global Affairs Canada said in a statement to The Canadian Press. “If they are in Russia or in Belarus, they should leave now. Our ability to provide consular services may become extremely limited.”

There could be a possibility that a situation similar to the imprisonment of U.S. WNBA athlete Brittney Griner could occur due to the ongoing conflict. According to Maria Popova, Associate Professor of Political Science at McGill University in Quebec, there is a real threat to players. “Anybody who is in Russia is always in danger of being framed, incarcerated, used as a pawn in whatever the local government, central government et cetera decides to do,” Popova said. “I think something like what happened to Brittney Griner is possible. The same playbook can be repeated in a case against a Canadian player for sure.”

Advertisement

Griner was detained in Russia on Feb. 17, just before Russia invaded Ukraine. Popova did add, however, that while there’s a risk for players playing abroad, she doesn’t see a clear reason why Russia would choose to detain more athletes. “I don’t see why Russia would try to use these people as a pawn because Canada is not Russia’s main problem in this war,” Popova said. “There isn’t really any hope that Russia could change Canadian policy in Ukraine. They know Canada is firmly in NATO, clearly backing Ukraine.”

Adrien Blanchard, press secretary for Canadian Foreign Affairs Minister Melanie Joly, told CBC.ca that players should explain why they are choosing to stay in Russia and Belarus. “President [Vladimir] Putin’s war in Ukraine is a war on freedom, on democracy and on the rights of Ukrainians, and all people, to determine their own future,” Blanchard said. “Athletes who decide to play and associate with Russia and Belarus should explain their decisions to the public.”

Player-agent Ritchie Winter, based in Alberta, manages three players currently involved in the Kontinental Hockey League. In his opinion, players have every right to continue making a living.

“We live in a world where individuals are allowed to make those decisions. It’s just an individual decision related to an employment opportunity. Has every player that’s gone, push, tugged and pulled and wrestled with the decision? Yeah, absolutely,” Winter said. “At the end of the day, they’re husbands and fathers who have responsibilities to their families. If you’re a young family with limited resources because you played mostly in the minors, there’s a desire to take care of your family. Sometimes that leads people to the oilfields in Kazakhstan and sometimes it leads them to the KHL.”

An NBC News report from March shared that players often compete in Russia because they can possibly earn four or five times more than their U.S. salaries. Citing Ketra Armstrong, a professor of sport management and the director of the Center for Race & Ethnicity in Sport at the University of Michigan. “It’s a sad situation in many regards, but it’s not totally beyond the realm of understanding,” said Armstrong. “The amount of money that athletes can make throughout other parts of the world is incredible and almost a no-brainer depending on how good you are and your overall market appeal.”

Advertisement

The National Hockey League (NHL) does conduct THCThis post contains affiliate links! drug tests on players, but CBDThis post contains affiliate links! is permitted. Rather than being punished for cannabisThis post contains affiliate links! use, the NHL refers the players to a Substance Abuse and Behavioral Health Program.



Source link

Continue Reading

What's Lit

Deadline Passes in New York for First Round of Dispensary Licenses

Published

on


The deadline for the first adult-use cannabis dispensary licenses in New York arrived on Monday, and now hundreds of applicants await feedback from the state.

Monday’s deadline came a month after the state’s Office of Cannabis Management officially opened the application portal on August 25.

Since then, the agency has been flooded with applications from individuals hoping for the first crack at the Empire State’s legal marijuanaThis post contains affiliate links! market.

Advertisement

Earlier this week, The New York Times reported that roughly “500 applications had been submitted by Sunday,” adding that hundreds “of ineligible people have been turned away, but so have dozens more who did qualify and needed help navigating the state’s online portal.”

The state will award 150 licenses for the first round this fall, and those have been designated exclusively for applicants who have previously been convicted of a pot-related offense (or a family member of someone who has).

Billed as the “Seeding Opportunity Initiative,” the policy goes further than most of the so-called “social equity” provisions in other states’ marijuanaThis post contains affiliate links! laws.

“New York State is making history, launching a first-of-its-kind approach to the cannabis industry that takes a major step forward in righting the wrongs of the past,” New York Gov. Kathy Hochul said in announcing the policy back in March. “The regulations advanced by the Cannabis Control Board today will prioritize local farmers and entrepreneurs, creating jobs and opportunity for communities that have been left out and left behind. I’m proud New York will be a national model for the safe, equitable and inclusive industry we are now building.”

New York City has taken similar steps toward enhancing opportunities in the emerging cannabis industry for individuals adversely affected by erstwhile marijuanaThis post contains affiliate links! laws.

Advertisement

The city’s mayor, Eric Adams, announced last month “a first-of-its-kind initiative and suite of services to support the equitable growth of the cannabisThis post contains affiliate links! industry in New York City.”

The initiative, known as Cannabis NYC, will provide “technical assistance for cannabis license applicants, as well as other business services to take entrepreneurs beyond licensing to a thriving operation,” while also supporting “cannabis entrepreneurs and their workers as the industry develops.”

It will also collaborate with “industry stakeholders to create good jobs, successful small businesses, and sustainable economic opportunities, while also addressing the harms of cannabis prohibition.” Adams’ office said that the “first phase of Cannabis NYC will focus on ensuring that justice involved New Yorkers are able to apply for and secure retail licenses from the state.”

“Today, we light up our economy and launch CannabisThis post contains affiliate links! NYC — a first-of-its-kind initiative to support equitable growth of the cannabis industry in New York City,” Adams said in a press release last month. “The regulated adult-use cannabis industry is a once-in-a-generation opportunity for our underserved communities that have, for too long, faced disproportionate rates of drug-related incarceration to get in on the industry on the ground floor. CannabisThis post contains affiliate links! NYC will plant the seeds for the economy of tomorrow by helping New Yorkers apply for licenses and understand how to open and successfully run a business, while simultaneously rolling equity into our economy by giving those who have been justice-involved and those with a cannabisThis post contains affiliate links! conviction a chance to succeed. This is about creating good jobs, successful small businesses, and finally delivering equity to communities harmed by the ‘War on Drugs.’”

The first state-regulated recreational cannabis dispensaries in New York are not expected to open until late this year (as the earliest).

Advertisement

But countless small business owners there have not waited to get in on the “kush rush.” New York City in particular is teeming with illicit cannabis shops, prompting state regulators to crack down on some.



Source link

Continue Reading

What's Lit

Is Big Tobacco Pivoting to Big Cannabis?

Published

on


British American Tobacco announced Monday that it has acquired a non-controlling minority stake in the Berlin-based marijuanaThis post contains affiliate links! startup Sanity Group GmbH.

Kingsley Wheaton, the chief growth officer at BAT, characterized the deal as an example of the company’s “ongoing work to explore numerous areas beyond nicotine, positioning BAT for future portfolio growth across a range of categories and geographies.”

“We continue to transform our business, through better understanding of our current and future consumers, as part of our A Better Tomorrow purpose,” Wheaton said in a press release. 

Advertisement

The acquisition could also be seen as a reflection of an emerging trend: cannabis is the future, while tobacco––specifically cigarettes––is increasingly a relic of the past.

A survey from Gallup last month found that a mere 11% of Americans reported as cigarette smokers, an all-time low. By contrast, 16% said they consider themselves current cannabis smokers.

Those consumer trends may continue to shift as marijuanaThis post contains affiliate links! becomes legal in more markets both in the United States and beyond.

In Germany, government officials are readying plans to legalize recreational cannabis, a move that will make the country the world’s largest legal marijuanaThis post contains affiliate links! market.

That coming change in policy almost certainly made Monday’s deal even more enticing for British American Tobacco, one of the largest tobacco companies in the world.

Advertisement

According to Bloomberg, Sanity “secured $37.6 million in the BAT-led Series B funding round,” noting that almost “half of the amount will go toward strengthening Sanity’s medical business, while the company will spend the rest on preparing for the potential legalization of recreational marijuana in Germany.”

Per Bloomberg, British American Tobacco made the investment along with Verde Capital, the investment fund co-founded by Snoop Dogg.

Sanity Group was founded in 2018 and now has more than 100 employees and has raised tens of millions from the likes of “Navy Capital, Redalpine, HV Capital, Calyx, Cherry Ventures, Bitburger Ventures, SOJE Capital, and various business angels and celebrities such as Will.i.am (Black Eyed Peas), Scooter Braun, Hollywood actor Alyssa Milano and German soccer player Mario Götze,” along with Verde Capital and now BAT.

The company says that its focus “is on pharmaceuticals (medical cannabis; finished pharmaceuticals) and medical products on the one hand, and cannabinoidThis post contains affiliate links!-based consumer goods on the other.”

Finn Age Hänsel, the founder and chief executive officer of Sanity Group, hailed the funding from British American Tobacco as “an important milestone for us and a strong signal towards the future of cannabis in Germany and Europe.”

Advertisement

“I am grateful for the belief shown by both new and existing investors. Our goal is to leverage the full potential of the cannabis plant and to explore and harness the different cannabinoids – with the new capital, we will be able to accelerate our medical and consumer business units whilst preparing accordingly for cannabis legalization in Germany,” Hänsel said in a statement, as quoted by Tech Funding News.

According to Max Narr, the chief investment officer for Sanity Group, the “financing round is not only the largest funding round achieved by a European cannabis company to date, but also one of the few upsizing rounds in this current economic phase of the German startup scene.”

Hänsel told Bloomberg that Sanity has attracted “strong interest, not only from tobacco, but also from other industries like fast-moving consumer companies.”

He also said that the German government is “working actively on [the new marijuana law] and really want to come to a good draft of the law by the end of this year.”

“This is really a priority topic for the government,” he said.

Advertisement



Source link

Continue Reading

What's Lit

House of Kush to Go Global with Clever Leaves, Bringing Classic Strains to the Masses

Published

on


Classic genetics such as Bubba Kush Pre-98 and OG Kush varieties will be available on a global scale, as two powerhouses team up. On September 21, Colombia-based multinational juggernaut Clever Leaves announced a partnership with legacy brand House of Kush, to be the exclusive grower and distributor of genetics globally.

Clever Leaves will produce genetics for House of Kush—thus expanding their reach outside of the United States and Canada.

Clever Leaves will cultivate House of Kush’s genetics at facilities in Colombia and Portugal over the course of the next three years. Clever Leaves’ footprint is global with smokable flower already being sold in Germany, Israel, and Australia.

Advertisement

Clever Leaves will produce House of Kush’s signature strain—Bubba Kush Pre-98—as well as other classics such as San Fernando Valley OG Kush. Different theories abound, but Bubba Kush appeared on the market in the ‘90s, noted by its sedative effects. People have turned to it to help with pain, anxiety, and insomnia.

The scale is massive: In Colombia, Clever Leaves boasts 18 hectares (44.4 acres) of cultivation. More importantly though, the company holds European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute – Invima, and Good Agricultural and Collecting Practices (GACP) Certification.

In Portugal, Clever Leaves operates on about nine million square feet of land, with 260,000 square feet of greenhouse facilities. They also have regulatory privilege there with a license from INFARMED I.P., the Portuguese pharmaceutical regulatory authority, with (EU-GMP) certification and are (GACP) certified.

Courtesy House of Kush

House of Kush Genetics

The partnership will deliver House of Kush’s genetics to a wider market. “Going international was really a big step,” says House of Kush co-founder and Chief Sales Officer Steve Gardner. “Clever Leaves do such good work. And we’ve been so impressed with them. And we’ve really been working on this deal for almost a year. But when you get plugged in with a group like that, that can take you all over the place.” Gardner’s roles as serial entrepreneur, advisor, investor in sports and entertainment date back 30 years.

“I would echo that sentiment and also just bring in the point that other countries are more quickly adopting and having more open, flexible laws than what we’re experiencing currently in the U.S.,” says House of Kush co-founder and Chief Executive Officer Reggie Harris. “So having the opportunity to get there early in our growth strategy not only helps us improve our status as a U.S. company, but everybody’s in the game to be able to spread that knowledge and the product and be able to get out there. So [it’s as much of an] exposure type thing as it is a financial benefit as well, that the two kind of go together. It’s not one without the other.” Harris’ background as a senior executive in sports and entertainment goes back two decades.

“Our first introduction to Bubba Kush was actually through Matt Bubba Berger, who was one of the original cultivators, and obviously Bubba Kush was part of that founding group that came up with OG Kush as well,” Harris adds. “And I was looking at it and reached out to Steve [Gardner] and said, ‘You know, I got this interesting call, product opportunity. Let’s go sit down and talk about it.’”

Advertisement

Protecting those genetics is another story. While House of Kush has explored blockchain technology and other ways of protecting their genetics, continuing to develop their reputation as a brand is more valuable.

“The biggest protection for us is quality assurance,” Harris adds. “We’ve created a kush certified program, to where we go through and we tell people, these are the recommended ways of growing the genetics, this is the proper way, the proper soil, the proper water, all that type of stuff, because we know ultimately, right now, federally, we can’t protect it, it’s going to be some somebody could take it, we will lose more money trying to defend it, then we will just go on out being better than they are. So we spent a lot of time just trying to have the great genetics and the great SOPs around that to make sure that it comes out right on the other side and up to our standard.”

Gustavo Escobar / Courtesy Clever Leaves

Regulatory Perks of Going International

Clever Leaves’ footprint is all over the globe, but each facility has a distinctive purpose. “We have two facilities, one in Colombia, one in Portugal,” says Julián Wilches, co-founder and Chief Regulatory Officer of Clever Leaves. “The Portugal facility is focused on flower. And in Colombia, the Colombian facility has been focused on extracts, raw materials, and finished products such as oils. Now, we have the opportunity, also of exporting flower from Colombia, which is something that we plan to do in the coming months. But now it is very important for us and we’re going to have access to additional genetics.”

One of Clever Leaves’ advantages is holding certifications in Europe. But one of the keys to growth is expanding internationally to improve chances of success.

“If you cultivate in the U.S., you cannot export it, because of the federal prohibition in the U.S.,” says Gustavo Escobar, co-founder and Chief Operating Officer of Clever Leaves. “So the fact that we can cultivate in Colombia and export it for medicinal purposes, opens the global market. We’re focused on four markets in addition to the U.S.: Australia, Israel, Germany, and Brazil. In Brazil, we cannot sell flower. So I would say three markets for flower: Israel, Australia, and Germany. But there are additional markets like Portugal and Italy, U.K., Ireland, most likely France, and Spain. Now we have Thailand. So the world is moving towards medicine and medicinal legalization.”

The partnership benefits both companies in ways that were not possible before.

Advertisement

“Working together, you can do better things,” Wilches adds. “So partnering with people with good genetics, and having the capabilities that were described—that will give us a better opportunity of success in those markets. So we believe in partnerships and we believe in working together and creating long-term relationships for being in the market in the long term with really high quality and good product.”



Source link

Continue Reading

Trending